Melek Karakurt Eryılmaz

Author

Also Known As

M Eryilmaz, M. Karakurt Eryilmaz, Melek Eryilmaz, Melek K Eryılmaz, Melek KARAKURT ERYILMAZ, Melek Karakurt ERYILMAZ, Melek Karakurt Eryilmaz, Melek Karakurt Eryılmaz, Melek karakurt eryılmaz, Muhammet Emre Eryilmaz

114

Publications

366

Citations

H-Index

Concepts

All Affiliations

Necmettin Erbakan University Akdeniz University Okmeydanı Eğitim ve Araştırma Hastanesi Antalya Eğitim ve Araştırma Hastanesi Selçuk University

About

Melek Karakurt Eryılmaz is an author at Necmettin Erbakan University specializing in oncology, medicine, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	50
2	Pathology	2	2	30
3	Immunology	1	1	16
4	Pharmacology	1	1	20
5	Cancer Therapeutics	1	1	20

Melek Karakurt Eryılmaz

Publications

176

Citations

H-Index

Page 1

	Year	Citations
The Neutrophil to Lymphocyte Ratio has a High Negative Predictive Value for Pathologic Complete Response in Locally Advanced Breast Cancer Patients Receiving Neoadjuvant Chemotherapy Melek Karakurt Eryılmaz, Hasan Mutlu, Derya Kıvrak Salim, Asian Pacific Journal of Cancer Prevention	2014	37
Molecular Types and Neoadjuvant Chemotherapy in Patients with Breast Cancer- While Molecular Shifting is More Common in Luminal a Tumors, The Pathologic Complete Response is Most Frequently Observed in Her-2 Like Tumors Derya Kıvrak Salim, Hasan Mutlu, Melek Karakurt Eryılmaz, Asian Pacific Journal of Cancer Prevention	2014	23
Primary Tumor Resection and Survival in Patients with Stage IV Gastric Cancer Fatma Yalçın Müsri, Hasan Mutlu, Mustafa Karaağaç, Journal of the Korean Gastric Cancer Association	2016	22
The effect of concomitant use of proton pump inhibitors with CDK 4/6 inhibitors on survival in metastatic breast cancer Dilek Çağlayan, Mehmet Koçak, Çağlayan Geredeli, European Journal of Clinical Pharmacology Metastatic Breast CancerBreast OncologyMedicinePharmacologyProton Pump Inhibitors	2022	20
Prognostic biomarkers in metastatic colorectal cancer: delta prognostic nutritional index, delta neutrophil to lymphocyte ratio, and delta platelet to lymphocyte ratio Mehmet Zahid Koçak, S. Arguvanli Çoban, Murat Araz, Supportive Care in Cancer Biomarker (Medicine)Prognostic BiomarkersDelta PlateletMedicinePrognosis	2023	16
The Prognostic Value of Serum Semaphorin3A and VEGF Levels in Patients with Metastatic Colorectal Cancer Tuba Karpuz, Murat Araz, Levent Korkmaz, Journal of Gastrointestinal Cancer Prognostic BiomarkersSerum Semaphorin3aMedicinePathologyColorectal Cancer	2019	14
Could the concomitant use of beta blockers with bevacizumab improve survival in metastatic colon cancer? Mehmet Zahid Koçak, Muhiddin Er, Muzaffer Uğraklı, European Journal of Clinical Pharmacology	2023	12
Prognostic Significance of Radiologic Extranodal Extension in Nasopharyngeal Cancer Melek Karakurt Eryılmaz, Cengiz Kadıyoran Otolaryngology	2021	11
Ribociclib-induced hepatotoxicity Muhammed Muhiddin Er, Murat Araz, Engin Hendem, Journal of Oncology Pharmacy Practice	2023	11
Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group Çağlar Ünal, Abdulmunir Azizy, Senem Karabulut, The Oncologist	2023	10

Page 1